Could a common heart drug boost bladder cancer treatment?
NCT ID NCT07353294
First seen Jan 27, 2026 · Last updated May 20, 2026 · Updated 16 times
Summary
This early-phase study tests whether adding the blood-pressure drug propranolol to standard immunotherapy and chemotherapy can improve outcomes for people with bladder cancer that has spread to nearby lymph nodes. About 12 participants will receive the combination before surgery to remove their bladder. The main goal is to check safety, but researchers will also look for signs that the cancer disappears completely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER UROTHELIAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.